Product
Liposomal Placebo
1 clinical trial
4 indications
Indication
Bronchiolitis Obliterans SyndromeIndication
Graft-versus-host diseaseIndication
ChronicIndication
Stem Cell Transplant ComplicationsClinical trial
A Phase IIa Multi-Center, Randomized, Single-Blind Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell TransplantationStatus: Terminated, Estimated PCD: 2022-06-16